JP Morgan Chase’s Aceragen Inc ACGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10
| Closed | -$16 | – | 7844 |
|
|
2023
Q2 | $16 | Hold |
10
| – | – | ﹤0.01% | 6798 |
|
|
2023
Q1 | $0 | Sell |
10
-2
| -17% | -$10 | ﹤0.01% | 7414 |
|
|
2022
Q4 | $0 | Hold |
12
| – | – | ﹤0.01% | 7199 |
|
|
2022
Q3 | $0 | Buy |
+12
| New | +$90 | ﹤0.01% | 7024 |
|
|
2021
Q3 | – | Sell |
-28
| Closed | -$1K | – | 6937 |
|
|
2021
Q2 | $1K | Buy |
+28
| New | +$564 | ﹤0.01% | 6285 |
|
|
2021
Q1 | – | Sell |
-1,230
| Closed | -$77K | – | 6463 |
|
|
2020
Q4 | $77K | Buy |
1,230
+1,229
| +122,900% | +$70.5K | ﹤0.01% | 5058 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 5885 |
|
|
2020
Q2 | $0 | Sell |
1
-3,846
| -100% | -$119K | ﹤0.01% | 5801 |
|
|
2020
Q1 | $86K | Sell |
3,847
-1,645
| -30% | -$44.7K | ﹤0.01% | 4566 |
|
|
2019
Q4 | $170K | Sell |
5,492
-2,643
| -32% | -$98.3K | ﹤0.01% | 4737 |
|
|
2019
Q3 | $399K | Buy |
+8,135
| New | +$357K | ﹤0.01% | 4277 |
|
|
2019
Q2 | – | Sell |
-4,173
| Closed | -$181K | – | 6090 |
|
|
2019
Q1 | $181K | Buy |
4,173
+659
| +19% | +$31.9K | ﹤0.01% | 4665 |
|
|
2018
Q4 | $166K | Buy |
3,514
+3,254
| +1,252% | +$374K | ﹤0.01% | 4669 |
|
|
2018
Q3 | $39K | Buy |
260
+8
| +3% | +$1.14K | ﹤0.01% | 5282 |
|
|
2018
Q2 | $45K | Sell |
252
-19,884
| -99% | -$4.64M | ﹤0.01% | 5112 |
|
|
2018
Q1 | $5.03M | Sell |
20,136
-3,918
| -16% | -$1.07M | ﹤0.01% | 2567 |
|
|
2017
Q4 | $6.9M | Sell |
24,054
-676
| -3% | -$193K | ﹤0.01% | 2412 |
|
|
2017
Q3 | $7.53M | Buy |
24,730
+7,717
| +45% | +$2.02M | ﹤0.01% | 2227 |
|
|
2017
Q2 | $3.98M | Sell |
17,013
-4,770
| -22% | -$1.25M | ﹤0.01% | 2629 |
|
|
2017
Q1 | $7.31M | Sell |
21,783
-52
| -0.2% | -$12.5K | ﹤0.01% | 2153 |
|
|
2016
Q4 | $4.45M | Sell |
21,835
-293
| -1% | -$69.9K | ﹤0.01% | 2547 |
|
|
2016
Q3 | $7.7M | Sell |
22,128
-1,535
| -6% | -$406K | ﹤0.01% | 1953 |
|
|
2016
Q2 | $4.92M | Sell |
23,663
-992
| -4% | -$219K | ﹤0.01% | 2308 |
|
|
2016
Q1 | $6.63M | Buy |
24,655
+1,381
| +6% | +$369K | ﹤0.01% | 2038 |
|
|
2015
Q4 | $9.77M | Buy |
23,274
+8,568
| +58% | +$3.83M | ﹤0.01% | 1840 |
|
|
2015
Q3 | $6.69M | Buy |
14,706
+6,304
| +75% | +$2.79M | ﹤0.01% | 2040 |
|
|
2015
Q2 | $4.24M | Buy |
8,402
+8,235
| +4,931% | +$3.78M | ﹤0.01% | 2494 |
|
|
2015
Q1 | $84K | Buy |
+167
| New | +$102K | ﹤0.01% | 3914 |
|
|
2014
Q2 | – | Sell |
-473
| Closed | -$262K | – | 3648 |
|
|
2014
Q1 | $262K | Buy |
+473
| New | +$324K | ﹤0.01% | 3336 |
|
Other funds holding ACGN
JP Morgan Chase's ACGN Position: Q3 2023 in Review
JP Morgan Chase sold out of Aceragen Inc (ACGN) in Q3 2023, closing a stake of 10 shares — an estimated $16 sold.
JP Morgan Chase first reported a position in ACGN in Q1 2014 and held it in 29 quarters. The position peaked at $9.77M in Q4 2015. 3 funds tracked by Wall St. Rank hold ACGN as of Q3 2023.
- JP Morgan Chase reported no remaining Aceragen Inc position as of Q3 2023 after selling out during the quarter.
- JP Morgan Chase sold 10 Aceragen Inc shares in Q3 2023, an estimated $16.
- JP Morgan Chase first reported a position in Aceragen Inc in Q1 2014 and held it in 29 quarters.
- JP Morgan Chase's Aceragen Inc position peaked at $9.77M in Q4 2015.
- 3 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2023.
Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.